Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for MNKD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 69.00%
March 31, 2026 75.78%
December 31, 2025 69.95%
September 30, 2025 75.40%
June 30, 2025 73.12%
March 31, 2025 77.64%
December 31, 2024 74.47%
September 30, 2024 74.28%
June 30, 2024 71.85%
March 31, 2024 71.93%
December 31, 2023 69.10%
September 30, 2023 72.19%
June 30, 2023 70.71%
March 31, 2023 60.09%
December 31, 2022 55.28%
September 30, 2022 46.81%
June 30, 2022 31.64%
March 31, 2022 8.29%
December 31, 2021 8.64%
September 30, 2021 55.49%
June 30, 2021 57.36%
March 31, 2021 56.35%
December 31, 2020 65.93%
September 30, 2020 66.31%
June 30, 2020 62.55%
Date Value
March 31, 2020 53.64%
December 31, 2019 56.10%
September 30, 2019 38.78%
June 30, 2019 56.90%
March 31, 2019 68.15%
December 31, 2018 62.12%
September 30, 2018 -16.42%
June 30, 2018 -18.03%
March 31, 2018 -15.67%
December 31, 2017 -10.77%
September 30, 2017 -123.9%
June 30, 2017 -135.1%
March 31, 2017 15.32%
December 31, 2016 5.01%
September 30, 2016 83.57%
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
United Therapeutics Corp. 87.30%
ACADIA Pharmaceuticals, Inc. 90.81%
Gilead Sciences, Inc. 79.81%
Vertex Pharmaceuticals, Inc. 85.37%
Ocugen, Inc. 60.62%

Gross Profit Margin (Quarterly) Related Metrics